These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 10839290

  • 1. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
    Propper DJ, Levitt NC, O'Byrne K, Braybrooke JP, Talbot DC, Ganesan TS, Thompson CH, Rajagopalan B, Littlewood TJ, Dixon RM, Harris AL.
    Br J Cancer; 2000 Jun; 82(11):1776-82. PubMed ID: 10839290
    [Abstract] [Full Text] [Related]

  • 2. A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
    Philip PA, Thompson CH, Carmichael J, Rea D, Mitchell K, Taylor DJ, Stuart NS, Dennis I, Rajagopalan B, Ganesan T.
    Cancer Res; 1993 Dec 01; 53(23):5649-53. PubMed ID: 8242619
    [Abstract] [Full Text] [Related]

  • 3. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H, Kornmann M.
    Anticancer Res; 2003 Dec 01; 23(6D):5203-8. PubMed ID: 14981990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassineti GL, Aschele C, Ravaioli A, Testore P, Caroti C, Gallo L, Pessi MA, Cortesi E, Turci D, Grossi F, Labianca R.
    Br J Cancer; 2001 Apr 20; 84(8):1023-8. PubMed ID: 11308248
    [Abstract] [Full Text] [Related]

  • 6. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952
    [Abstract] [Full Text] [Related]

  • 7. [Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer].
    Yoshimura K, Hazama S, Iizuka N, Takano N, Matsuoka K, Tangoku A, Oka M.
    Gan To Kagaku Ryoho; 2002 Nov 01; 29(12):2117-20. PubMed ID: 12484016
    [Abstract] [Full Text] [Related]

  • 8. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 Nov 01; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 9. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
    Chau I, Webb A, Cunningham D, Hill M, Waters JS, Norman A, Massey A.
    Br J Cancer; 2001 Nov 02; 85(9):1258-64. PubMed ID: 11720458
    [Abstract] [Full Text] [Related]

  • 10. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T, Yabe K, Oka H, Kouzuma T, Kawahara H, Wakayama T, Sugiura A, Hagiwara M, Ohdate K, Miyajima N, Maeda C, Okamura R, Miyahara T, Moriyama Y, Yamaguchi S, Gunji A, Intraportal Chemotherapy for Colorectal Cancer Group.
    Gan To Kagaku Ryoho; 2002 Oct 02; 29(10):1765-71. PubMed ID: 12402427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K, Happich K, Schirner I, Jüngert B, Brückl V, Männlein G, Brückl WM, Merkel S, Göhl J, Hohenberger W, Hahn EG, Wein A.
    Anticancer Res; 2004 Oct 02; 24(1):385-91. PubMed ID: 15015625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BW12C: effects on tumour hypoxia, tumour thermosensitivity and relative tumour and normal tissue perfusion in C3H mice.
    Honess DJ, Hu DE, Bleehen NM.
    Br J Cancer; 1991 Oct 02; 64(4):715-22. PubMed ID: 1911220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.